Track topics on Twitter Track topics that are important to you
One Financial Center
United States of America
In the July issue of Life Science Leader, Cliff Mintz wrote a global update on follow-on biologics in unregulated markets, the European Union, and the United States. By Life Science Leader magazine.
The debate over whether or not lower cost, “generic” versions of biologics and biotechnology drugs ought to be brought to market has been a very long and contentious one. However, rising...
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo is a versatile law firm of more than 450 highly qualified and dedicated attorneys representing diverse international clients in many industries, who turn ...
We have published hundreds of Mintz news stories on BioPortfolio along with dozens of Mintz Clinical Trials and PubMed Articles about Mintz for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Mintz Companies in our database. You can also find out about relevant Mintz Drugs and Medications on this site too.
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...